For estimation of [123I]-VEGF as a prognostic marker in the group of grade IV glioma, a T/N ratio threshold of 1.75 in [123I]-VEGF SPECT at 18 h post injection was used based on the ROC analysis. This evidence concerns the gene VEGFA and central nervous system cancer.